High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors
Takatsugu Yamamoto,
Takatsugu Yamamoto
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Koichiro Abe,
Koichiro Abe
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Kengo Hattori,
Kengo Hattori
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Taro Ishii,
Taro Ishii
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Yasushi Kuyama,
Yasushi Kuyama
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author
Takatsugu Yamamoto,
Takatsugu Yamamoto
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Koichiro Abe,
Koichiro Abe
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Kengo Hattori,
Kengo Hattori
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Taro Ishii,
Taro Ishii
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author Yasushi Kuyama,
Yasushi Kuyama
Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
Search for more papers by this author
First published: 15 December 2009
No abstract is available for this article.
REFERENCES
- 1
Loke YK,
Trivedi AN,
Singh S et al.
Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs.
Aliment. Pharmacol. Ther.
2008; 27: 31–40.
- 2
Opatrny L,
Delaney JA,
Suissa S et al.
Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look.
Br. J. Clin. Pharmacol.
2008; 66: 76–81.
